CICigna

$275.84
Latest close: below its 200-day averageSep 8, 2026what changed →

The financials

Cigna by the numbers

Cigna (CI) reported revenue of $71.7B in Q2 2026 (quarter ended Jun 30, 2026), up 6.7% from the same quarter a year earlier. That came with a gross margin of 21% and net income of $1.88B (2.6% of revenue). For the full year FY2025, revenue was $274.9B (+11% year on year) and net income $6.29B. Its largest product in Q2 2026 was Network Pharmacy at $33.3B, 50% of the disclosed total, ahead of Home Delivery And Specialty at 31%.

Cigna income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$71.7B$67.2B+6.7%
Gross profit$15.0B$13.9B+7.6%
Operating income$2.68B$2.31B+16%
Net income$1.88B$1.63B+15%
Diluted EPS$6.29$5.71+10%
Revenue by product, Q2 2026, as reported to the SEC
ProductRevenueShare
Network Pharmacy$33.3B50%
Home Delivery And Specialty$20.4B31%
Service$4.37B6.6%
Service Fees And Other$3.96B6.0%
Other Pharmacy$3.72B5.6%
Service Other$315M0.5%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q2 2026Total $66.13B (+4.9%)
Service Other grew +176% year on yearHome Delivery And Specialty +2.4% year on year
  • Network Pharmacy$33.33BQoQ +7.2%year on year +9.0%
  • Home Delivery And Specialty$20.44BQoQ +3.3%year on year +2.4%
  • Service$4.37BQoQ -1.8%year on year +5.5%
  • Service Fees And Other$3.96BQoQ -4.0%year on year +4.0%
  • Other Pharmacy$3.72BQoQ +8.6%year on year +8.4%
  • Service Other$315.0MQoQ +98%year on year +176%
Segment sum = 92% of reported consolidated revenue · Latest source: 10-Q filed 2026-07-30, SEC EDGAR